Alternatives to ImmunoScape
ImmunoScape is a Biotechnology tool: developing novel immunotherapies and diagnostics for cancer. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to ImmunoScape
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
ImCheck Therapeutics60BiotechMarseille, France$164.0MImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.
- Website
Pyxis Diagnostics51HealthcareSan Diego, United States$10.0MDeveloping novel diagnostics to predict patient response to immunotherapy.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
4D Path59BiotechnologyNewton, USA$17.4MPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
- Website
Janux Therapeutics57BiotechnologySan Diego, USA$181.0MA clinical-stage biopharmaceutical company developing novel immunotherapies.
- Website
LTZ Therapeutics49BiotechnologyRedwood City, USA$76.0MImmunotherapy company targeting oncology and autoimmune diseases.
- Website
Brenus Pharma48BiotechnologyLyon, France$12.6MClinical-stage immunotherapy company developing novel treatments for cancer.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Umlaut.bio35BiotechnologyCambridge, USA$3.0MDeveloping novel immunotherapies for cancer.
- Website AVAvant Genomics34BiotechnologyCharlottesville, USA$3.0M
Developing an automated platform for liquid biopsy sample preparation.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website MEME Therapeutics Holdings28BiotechnologyVancouver, Canada$500K
Biotechnology company developing novel cancer fighting drugs that reprogram and redirect immune cells to fight cancer.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Abcam61BiotechnologyCambridge, United Kingdom$256.9MGlobal supplier of life science research tools, including antibodies, reagents, and assays.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Showing the 20 closest matches. See the rest on the ImmunoScape profile.
Compare ImmunoScape head to head
Side by side on what each one does, what it costs, and what real users report.